Logo image of ALSEN.PA

SENSORION SA (ALSEN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALSEN - FR0012596468 - Common Stock

0.328 EUR
-0.02 (-4.93%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALSEN gets a fundamental rating of 3 out of 10. We evaluated ALSEN against 82 industry peers in the Biotechnology industry. The financial health of ALSEN is average, but there are quite some concerns on its profitability. ALSEN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALSEN has reported negative net income.
In the past year ALSEN has reported a negative cash flow from operations.
In the past 5 years ALSEN always reported negative net income.
In the past 5 years ALSEN always reported negative operating cash flow.
ALSEN.PA Yearly Net Income VS EBIT VS OCF VS FCFALSEN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

ALSEN has a Return On Assets of -38.36%. This is comparable to the rest of the industry: ALSEN outperforms 41.46% of its industry peers.
With a Return On Equity value of -49.12%, ALSEN perfoms like the industry average, outperforming 54.88% of the companies in the same industry.
Industry RankSector Rank
ROA -38.36%
ROE -49.12%
ROIC N/A
ROA(3y)-45.21%
ROA(5y)-34.89%
ROE(3y)-69.61%
ROE(5y)-51.71%
ROIC(3y)N/A
ROIC(5y)N/A
ALSEN.PA Yearly ROA, ROE, ROICALSEN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

ALSEN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSEN.PA Yearly Profit, Operating, Gross MarginsALSEN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for ALSEN has been increased compared to 1 year ago.
The number of shares outstanding for ALSEN has been increased compared to 5 years ago.
The debt/assets ratio for ALSEN has been reduced compared to a year ago.
ALSEN.PA Yearly Shares OutstandingALSEN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALSEN.PA Yearly Total Debt VS Total AssetsALSEN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.27 indicates that ALSEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.27, ALSEN is doing good in the industry, outperforming 65.85% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that ALSEN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, ALSEN is doing good in the industry, outperforming 76.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACCN/A
ALSEN.PA Yearly LT Debt VS Equity VS FCFALSEN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

ALSEN has a Current Ratio of 5.00. This indicates that ALSEN is financially healthy and has no problem in meeting its short term obligations.
ALSEN has a better Current ratio (5.00) than 78.05% of its industry peers.
A Quick Ratio of 5.00 indicates that ALSEN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.00, ALSEN belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5
Quick Ratio 5
ALSEN.PA Yearly Current Assets VS Current LiabilitesALSEN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.00% over the past year.
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ALSEN will show a very strong growth in Earnings Per Share. The EPS will grow by 42.52% on average per year.
Based on estimates for the next years, ALSEN will show a very strong growth in Revenue. The Revenue will grow by 69.24% on average per year.
EPS Next Y13.89%
EPS Next 2Y24.72%
EPS Next 3Y14.47%
EPS Next 5Y42.52%
Revenue Next Year17.4%
Revenue Next 2Y36.53%
Revenue Next 3Y15.46%
Revenue Next 5Y69.24%

3.3 Evolution

ALSEN.PA Yearly Revenue VS EstimatesALSEN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
ALSEN.PA Yearly EPS VS EstimatesALSEN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALSEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALSEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSEN.PA Price Earnings VS Forward Price EarningsALSEN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSEN.PA Per share dataALSEN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

ALSEN's earnings are expected to grow with 14.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.72%
EPS Next 3Y14.47%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SENSORION SA

EPA:ALSEN (12/19/2025, 7:00:00 PM)

0.328

-0.02 (-4.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-17 2025-09-17
Earnings (Next)03-12 2026-03-12/amc
Inst Owners53%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap98.62M
Revenue(TTM)N/A
Net Income(TTM)-28.00M
Analysts86.15
Price Target2.35 (616.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.73
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.36%
ROE -49.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.21%
ROA(5y)-34.89%
ROE(3y)-69.61%
ROE(5y)-51.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -376.71%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5
Quick Ratio 5
Altman-Z 2.27
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)189.86%
Cap/Depr(5y)143.46%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y13.89%
EPS Next 2Y24.72%
EPS Next 3Y14.47%
EPS Next 5Y42.52%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year17.4%
Revenue Next 2Y36.53%
Revenue Next 3Y15.46%
Revenue Next 5Y69.24%
EBIT growth 1Y-20%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.76%
EBIT Next 3Y13.96%
EBIT Next 5Y38.57%
FCF growth 1Y-25.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.65%
OCF growth 3YN/A
OCF growth 5YN/A

SENSORION SA / ALSEN.PA FAQ

What is the ChartMill fundamental rating of SENSORION SA (ALSEN.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSEN.PA.


What is the valuation status for ALSEN stock?

ChartMill assigns a valuation rating of 0 / 10 to SENSORION SA (ALSEN.PA). This can be considered as Overvalued.


Can you provide the profitability details for SENSORION SA?

SENSORION SA (ALSEN.PA) has a profitability rating of 1 / 10.